Dr. Agarwal on Drug Development in Metastatic Castration-Sensitive Prostate Cancer

Neeraj Agarwal, MD, associate professor of medicine, University of Utah School of Medicine; and director, Genitourinary Oncology Program, Oncology Division, co-leader, Urologic Oncology Multidisciplinary Program, associate director of Clinical Trials, Huntsman Cancer Institute, discusses the need for further drug development in metastatic castration-sensitive prostate cancer.